ENDLESS Trademark

Trademark Overview


On Wednesday, January 13, 2021, a trademark application was filed for ENDLESS with the United States Patent and Trademark Office. The USPTO has given the ENDLESS trademark a serial number of 90464300. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, May 29, 2024. This trademark is owned by Laronde, Inc.. The ENDLESS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, in...

Testing, inspection, research, and development of pharmaceutical preparations for gene therapy
endless

General Information


Serial Number90464300
Word MarkENDLESS
Filing DateWednesday, January 13, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, May 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations, namely, nucleic acid therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders; pharmaceutical preparations, namely, RNA therapeutics for the treatment of genetic disorders, immune system related diseases and disorders, metabolic diseases and disorders, hematological diseases and disorders, cancer, neurological diseases and disorders, reproductive diseases and disorders, gynecological diseases and disorders, inflammatory diseases and disorders, cardiological diseases and disorders, respiratory diseases and disorders, gastroenterological diseases and disorders, musculoskeletal diseases and disorders, ophthalmological diseases and disorders, and dermatological diseases and disorders
Goods and ServicesTesting, inspection, research, and development of pharmaceutical preparations for gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAIL BIOMEDICINES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139

Party NameLaronde, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameLaronde, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Thursday, July 22, 2021ASSIGNED TO EXAMINER
Wednesday, August 4, 2021NON-FINAL ACTION WRITTEN
Wednesday, August 4, 2021NON-FINAL ACTION E-MAILED
Wednesday, August 4, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 1, 2021FINAL REFUSAL WRITTEN
Wednesday, April 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 20, 2022ASSIGNED TO LIE
Thursday, April 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 1, 2021FINAL REFUSAL E-MAILED
Monday, November 1, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, April 18, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 28, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 31, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 31, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 25, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 11, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022NOTICE OF ALLOWANCE CANCELLED
Monday, October 17, 2022NEW NOA TO ISSUE
Thursday, July 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 27, 2023SOU EXTENSION 1 FILED
Thursday, April 27, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, November 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2023SOU EXTENSION 2 FILED
Tuesday, November 14, 2023SOU EXTENSION 2 GRANTED
Wednesday, May 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, May 29, 2024SOU EXTENSION 3 FILED
Wednesday, May 29, 2024SOU EXTENSION 3 GRANTED
Thursday, May 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED